Key points from article :
Glaxo and Verily Life Sciences LLC, formerly Google Life Sciences, create Galvani Bioelectronics with $714 million budget.
Many biological processes are controlled by electrical signals transmitted from the nervous system to the body’s organs.
Distortions of signaling pathways involved in long-term diseases including diabetes, asthma and arthritis.
Treatments would work by attaching miniature electronic devices to individual nerves.